サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1519817

心房細動治療市場レポート：疾患タイプ、治療タイプ、エンドユーザー、地域別、2024年～2032年

Atrial Fibrillation Treatment Market Report by Disorder Type, Treatment Type, End-User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 142 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
心房細動治療市場レポート：疾患タイプ、治療タイプ、エンドユーザー、地域別、2024年～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の心房細動治療の市場規模は2023年に78億米ドルに達しました。今後、IMARC Groupは、2024年から2032年の間に10.3%の成長率（CAGR）を示し、2032年までに195億米ドルに達すると予測しています。

心房細動（AFib）とは、不規則で急速な心拍数を伴う心疾患のことで、脳卒中、心不全、その他の心臓関連合併症のリスクを高める。この状態では、心房上室が不規則に拍動し、心室下室と協調しないため、動悸、息切れ、疲労感を引き起こします。また、血栓の発生につながり、他の臓器への血流を阻害することもあります。心房細動の主な種類には、発作性心房細動、持続性心房細動、長期持続性心房細動、永続性心房細動があり、心臓の電気インパルスを調整する薬物やその他の介入によって治療することができます。

心血管疾患（CVDs）の有病率の上昇は、市場の成長を促進する重要な要因の一つです。このような疾患は、老年人口や、糖尿病、高血圧、心血管疾患（CVDs）などの他の病気を患っている人々の間で非常に多く見られます。このことは、世界中で着実に増加している老人人口とともに、市場の成長を後押ししています。さらに、低侵襲（MI）手術への嗜好の高まりも、小型化手術装置、インプラント手術、遠隔看護の需要に好影響を与えています。さらに、損傷した心臓組織を除去するためのカテーテルアブレーション装置や革新的なマッピング・記録システムの開発など、さまざまな技術的進歩も成長を促す要因となっています。その他の要因としては、ヘルスケアインフラの改善や医療科学分野における広範な研究開発（R&D）活動などがあり、市場をさらに牽引すると予測されています。

本レポートで扱う主な質問

  • 世界の心房細動治療市場はこれまでどのように推移し、今後どのように推移していくのか
  • 世界の心房細動治療市場に対するCOVID-19の影響はどのようなものか
  • 主要な地域市場はどこか
  • 疾患タイプ別の市場内訳は何か
  • 治療タイプ別の市場内訳は何か
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界における主要な促進要因と課題とは？
  • 世界の心房細動治療市場の構造と主要プレイヤーとは？
  • 業界における競争の程度とは？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の心房細動治療市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：疾患タイプ別

  • 発作性心房細動
    • 市場動向
    • 市場予測
  • 持続性心房細動
    • 市場動向
    • 市場予測
  • 永続性心房細動
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：治療タイプ別

  • 医療処置
    • 市場動向
    • 外科処置
      • メイズ手術
      • カテーテルアブレーション
    • 非外科用デバイス
      • 電気的除細動
      • 診断用カテーテル
      • マッピングと記録システム
      • 心臓モニター
      • アクセスデバイス
      • 左心耳および閉鎖デバイス
      • 心臓内心エコー検査（ICE）システム
    • 市場予測
  • 医薬品
    • 市場動向
    • 薬剤クラス
      • 抗凝固剤
      • 抗不整脈薬
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 心臓検査室
    • 市場動向
    • 市場予測
  • 外来手術センター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Atricure Inc.
    • Biotronik
    • Boston Scientific Corporation
    • Cardiofocus Inc.
    • Hansen Medical Inc.（Auris Health）
    • Johnson & Johnson
    • Siemens Healthineers
    • Stereotaxis Inc.
図表

List of Figures

  • Figure 1: Global: Atrial Fibrillation Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Atrial Fibrillation Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Atrial Fibrillation Treatment Market: Breakup by Disorder Type (in %), 2023
  • Figure 4: Global: Atrial Fibrillation Treatment Market: Breakup by Treatment Type (in %), 2023
  • Figure 5: Global: Atrial Fibrillation Treatment Market: Breakup by End-User (in %), 2023
  • Figure 6: Global: Atrial Fibrillation Treatment Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Atrial Fibrillation Treatment (Paroxysmal Atrial Fibrillation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Atrial Fibrillation Treatment (Paroxysmal Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Atrial Fibrillation Treatment (Persistent Atrial Fibrillation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Atrial Fibrillation Treatment (Persistent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Atrial Fibrillation Treatment (Permanent Atrial Fibrillation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Atrial Fibrillation Treatment (Permanent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Atrial Fibrillation Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Atrial Fibrillation Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Atrial Fibrillation Treatment (Medical Procedures) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Atrial Fibrillation Treatment Market (Medical Procedures): Breakup by Type (in %), 2023
  • Figure 18: Global: Atrial Fibrillation Treatment Market (Surgical Procedures): Breakup by Type (in %), 2023
  • Figure 19: Global: Atrial Fibrillation Treatment (Medical Procedures) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Atrial Fibrillation Treatment (Medication) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Atrial Fibrillation Treatment Market (Medication): Breakup by Drug Classes (in %), 2023
  • Figure 22: Global: Atrial Fibrillation Treatment (Medication) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Atrial Fibrillation Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Atrial Fibrillation Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Atrial Fibrillation Treatment (Cardiac Labs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Atrial Fibrillation Treatment (Cardiac Labs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Atrial Fibrillation Treatment (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Atrial Fibrillation Treatment (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Atrial Fibrillation Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Atrial Fibrillation Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia Pacific: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia Pacific: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Atrial Fibrillation Treatment Industry: SWOT Analysis
  • Figure 80: Global: Atrial Fibrillation Treatment Industry: Value Chain Analysis
  • Figure 81: Global: Atrial Fibrillation Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Atrial Fibrillation Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by Disorder Type (in Million US$), 2024-2032
  • Table 3: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
  • Table 4: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 5: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Atrial Fibrillation Treatment Market Structure
  • Table 7: Global: Atrial Fibrillation Treatment Market: Key Players
目次
Product Code: SR112024A2140

The global atrial fibrillation treatment market size reached US$ 7.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 19.5 Billion by 2032, exhibiting a growth rate (CAGR) of 10.3% during 2024-2032.

Atrial fibrillation (AFib) refers to a cardiac condition with irregular and rapid heart rate that increases the risks of stroke, heart failure and other heart-related complications. In this condition, the upper (atrial) chambers beat irregularly and out of coordination with the lower (ventricle) chambers of the heart, thereby causing heart palpitations, shortness of breath and fatigue. It can also lead to the development of blood clots that may disrupt the blood flow to other organs. The main types of AFib include paroxysmal, persistent, long-term persistent, and permanent AFib that can be treated with medications and other interventions to adjust the heart's electrical impulses.

The rising prevalence of cardiovascular diseases (CVDs) is one of the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs). This, along with the steadily increasing geriatric population across the globe, is providing a boost to the market growth. Furthermore, the increasing preference for minimally invasive (MI) surgical procedures is also creating a positive impact on the demand for miniaturized surgical devices, implant surgeries and remote nursing. Additionally, various technological advancements, such as the development of catheter ablation devices to remove damaged heart tissues and innovative mapping and recording systems, is acting as another growth-inducing factor. Other factors, including improvements in the healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global atrial fibrillation treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on disorder type, treatment type and end-user.

Breakup by Disorder Type:

Paroxysmal Atrial Fibrillation

Persistent Atrial Fibrillation

Permanent Atrial Fibrillation

Others

Breakup by Treatment Type:

Medical Procedures

Surgical Procedures

Maze Surgery

Catheter Ablation

Non-Surgical Procedures

Electric Cardioversion

Diagnostic Catheters

Mapping and Recording Systems

Cardiac Monitors

Access Devices

Left Atrial Appendage and Closure Devices

Intracardiac Echocardiography (ICE) Systems

Medication

Anticoagulants

Anti-Arrhythmics

Breakup by End-User:

Hospitals

Cardiac Labs

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Atricure Inc., Biotronik, Boston Scientific Corporation, Cardiofocus Inc., Hansen Medical Inc. (Auris Health), Johnson & Johnson, Siemens Healthineers, Stereotaxis Inc., etc.

Key Questions Answered in This Report:

  • How has the global atrial fibrillation treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global atrial fibrillation treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the disorder type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global atrial fibrillation treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Atrial Fibrillation Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Disorder Type

  • 6.1 Paroxysmal Atrial Fibrillation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Persistent Atrial Fibrillation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Permanent Atrial Fibrillation
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Medical Procedures
    • 7.1.1 Market Trends
    • 7.1.2 Surgical Procedures
      • 7.1.2.1 Maze Surgery
      • 7.1.2.2 Catheter Ablation
    • 7.1.3 Non-Surgical Devices
      • 7.1.3.1 Electric Cardioversion
      • 7.1.3.2 Diagnostic Catheters
      • 7.1.3.3 Mapping and Recording Systems
      • 7.1.3.4 Cardiac Monitors
      • 7.1.3.5 Access Devices
      • 7.1.3.6 Left Atrial Appendage and Closure Devices
      • 7.1.3.7 Intracardiac Echocardiography (ICE) Systems
    • 7.1.4 Market Forecast
  • 7.2 Medications
    • 7.2.1 Market Trends
    • 7.2.2 Drug Class
      • 7.2.2.1 Anticoagulants
      • 7.2.2.2 Anti-Arrhythmics
    • 7.2.3 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiac Labs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Surgical Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Atricure Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Biotronik
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Boston Scientific Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 SWOT Analysis
    • 13.3.5 Cardiofocus Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Hansen Medical Inc. (Auris Health)
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Johnson & Johnson
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Siemens Healthineers
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
    • 13.3.9 Stereotaxis Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis